CollPlant Biotechnologies (CLGN) EPS (Diluted) (2019 - 2026)

CollPlant Biotechnologies (CLGN) EPS (Diluted) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 67,011.97 Bn 67,011.68 Bn - 0.00
2 Nanobiotix 1,908.00 Bn 1,907.94 Bn - -
3 Akari Therapeutics 959.56 Bn 959.56 Bn - 0.00
4 BeOne Medicines 471.88 Bn 467.08 Bn 1.35 Bn 0.15
5 Vertex Pharmaceuticals 122.20 Bn 114.96 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 69.93 Bn 61.17 Bn 3.31 Bn 6.75
7 Belite Bio 62.34 Bn 62.34 Bn - 0.00
8 Argenx Se 55.85 Bn 50.67 Bn 1.41 Bn 7.33
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn 1.49
10 CollPlant Biotechnologies 4.62 Mn 4.62 Mn -243,000.00 -0.26

Historic Data

Download Data
DateValue
Mar 30, 2026 -0.26
Dec 31, 2025 -2.62
Sep 30, 2025 -0.30
Jun 30, 2025 0.27
Mar 30, 2025 -0.14
Dec 31, 2024 -2.33
Sep 30, 2024 -6,221.92
Jun 30, 2024 6,035.62
Mar 31, 2024 0.38
Dec 31, 2023 -2.14
Sep 30, 2023 -0.39
Jun 30, 2023 0.48
Mar 31, 2023 0.31
Dec 31, 2022 -2.46
Sep 30, 2022 -0.40
Jun 30, 2022 -0.38
Mar 31, 2022 0.35
Dec 31, 2021 -19.02
Sep 30, 2021 5.82
Jun 30, 2021 -5,143.10